Literature DB >> 8490637

Cluster B personality disorder characteristics predict outcome in the treatment of bulimia nervosa.

E M Rossiter1, W S Agras, C F Telch, J A Schneider.   

Abstract

The Personality Disorders Examination (PDE) was administered to 71 bulimia nervosa patients at baseline assessment in a study comparing the effectiveness of cognitive-behavioral treatment with desipramine or the combination of both treatments. Personality disorder subscales were combined into single DSM-III-R cluster scores. A high cluster B score (consisting of antisocial, borderline, histrionic, and narcissistic features) significantly predicted poor outcome at 16 weeks and was a better predictor of outcome than borderline personality characteristics alone or any other DSM-III-R cluster score or combination of cluster scores. In contrast pretreatment depression level, self-esteem, degree of dietary restraint, frequency of purging, and history of anorexia nervosa were not significantly related to outcome. At 1-year follow-up there was still a trend toward high cluster B scores predicting poor treatment outcome. Cluster B score was not significantly correlated with percentage of sessions attended nor did subjects with higher cluster B scores have a better outcome with either specific treatment. These results suggest that further investigation of alternative treatments is warranted with high cluster B individuals to determine if treatment effectiveness can be improved.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8490637     DOI: 10.1002/1098-108x(199305)13:4<349::aid-eat2260130403>3.0.co;2-c

Source DB:  PubMed          Journal:  Int J Eat Disord        ISSN: 0276-3478            Impact factor:   4.861


  17 in total

Review 1.  Extracts from "Clinical evidence": Bulimia nervosa.

Authors:  P J Hay; J Bacaltchuk
Journal:  BMJ       Date:  2001-07-07

Review 2.  Stability and course of personality disorders: the need to consider comorbidities and continuities between axis I psychiatric disorders and axis II personality disorders.

Authors:  C M Grilo; T H McGlashan; A E Skodol
Journal:  Psychiatr Q       Date:  2000

3.  Association between depressive symptoms, weight and treatment outcome in a very large anorexia nervosa sample.

Authors:  Ulrich Voderholzer; Susanne Witte; Sandra Schlegl; Stefan Koch; Ulrich Cuntz; Caroline Schwartz
Journal:  Eat Weight Disord       Date:  2015-10-06       Impact factor: 4.652

4.  Temperament and character inventory and pharmacotherapeutic outcome in bulimia nervosa.

Authors:  F Rybakowski; A Slopien; R Komorowska; R Antkowiak; R Ciesielski; A Rajewski
Journal:  Eat Weight Disord       Date:  2005-06       Impact factor: 4.652

5.  Depression, worry, and psychosocial functioning predict eating disorder treatment outcomes in a residential and partial hospitalization setting.

Authors:  Laura K Fewell; Cheri A Levinson; Lynn Stark
Journal:  Eat Weight Disord       Date:  2017-03-07       Impact factor: 4.652

Review 6.  Bulimia nervosa.

Authors:  Phillipa J Hay; Angélica Medeiros Claudino
Journal:  BMJ Clin Evid       Date:  2010-07-19

Review 7.  Temperament and character in eating disorders: ten years of studies.

Authors:  S Fassino; F Amianto; C Gramaglia; F Facchini; G Abbate Daga
Journal:  Eat Weight Disord       Date:  2004-06       Impact factor: 4.652

8.  Countertransference reactions to adolescents with eating disorders: relationships to clinician and patient factors.

Authors:  Dana A Satir; Heather Thompson-Brenner; Christina L Boisseau; Michele A Crisafulli
Journal:  Int J Eat Disord       Date:  2009-09       Impact factor: 4.861

9.  Personality dimensions in bulimia nervosa, binge eating disorder, and obesity.

Authors:  Carol B Peterson; Paul Thuras; Diann M Ackard; James E Mitchell; Kelly Berg; Nora Sandager; Stephen A Wonderlich; Melissa W Pederson; Scott J Crow
Journal:  Compr Psychiatry       Date:  2009-05-02       Impact factor: 3.735

Review 10.  Bulimia nervosa.

Authors:  Phillipa J Hay; Josue Bacaltchuk
Journal:  BMJ Clin Evid       Date:  2008-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.